253 related articles for article (PubMed ID: 18528960)
1. Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever.
Tweezer-Zaks N; Rabinovich E; Lidar M; Livneh A
J Rheumatol; 2008 Jul; 35(7):1362-5. PubMed ID: 18528960
[TBL] [Abstract][Full Text] [Related]
2. Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine.
Lidar M; Kedem R; Langevitz P; Pras M; Livneh A
J Rheumatol; 2003 Dec; 30(12):2620-3. PubMed ID: 14719203
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study.
Tunca M; Tankurt E; Akbaylar Akpinar H; Akar S; Hizli N; Gönen O
Br J Rheumatol; 1997 Sep; 36(9):1005-8. PubMed ID: 9376975
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.
Calguneri M; Apras S; Ozbalkan Z; Ozturk MA; Ertenli I; Kiraz S
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S41-4. PubMed ID: 15515783
[TBL] [Abstract][Full Text] [Related]
5. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
[TBL] [Abstract][Full Text] [Related]
6. Colchicine therapy and the cognitive status of elderly patients with familial Mediterranean fever.
Leibovitz A; Lidar M; Baumoehl Y; Livneh A; Segal R
Isr Med Assoc J; 2006 Jul; 8(7):469-72. PubMed ID: 16889161
[TBL] [Abstract][Full Text] [Related]
7. The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial.
Tunca M; Akar S; Soytürk M; Kirkali G; Resmi H; Akhunlar H; Gönen O; Gallimore JR; Hawkins PN; Tankurt E
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S37-40. PubMed ID: 15515782
[TBL] [Abstract][Full Text] [Related]
8. Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures.
Abedat S; Urieli-Shoval S; Shapira E; Calko S; Ben-Chetrit E; Matzner Y
Isr Med Assoc J; 2002 Jan; 4(1):7-12. PubMed ID: 11802319
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
Grossman C; Farberov I; Feld O; Livneh A; Ben-Zvi I
Rheumatol Int; 2019 Mar; 39(3):517-523. PubMed ID: 30604205
[TBL] [Abstract][Full Text] [Related]
10. Absence of interferon activity during acute attacks of familial Mediterranean fever.
Aderka D; Pras M; Bino T; Rosenberg H; Weinberger A; Pinkhas J
Biomedicine; 1980; 33(4):95-6. PubMed ID: 6159009
[TBL] [Abstract][Full Text] [Related]
11. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.
Tufan A; Babaoglu MO; Akdogan A; Yasar U; Calguneri M; Kalyoncu U; Karadag O; Hayran M; Ertenli AI; Bozkurt A; Kiraz S
J Rheumatol; 2007 Jul; 34(7):1540-4. PubMed ID: 17610314
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
Calligaris L; Marchetti F; Tommasini A; Ventura A
Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of ischemic heart disease in patients with familial Mediterranean fever.
Langevitz P; Livneh A; Neumann L; Buskila D; Shemer J; Amolsky D; Pras M
Isr Med Assoc J; 2001 Jan; 3(1):9-12. PubMed ID: 11344818
[TBL] [Abstract][Full Text] [Related]
14. [Familial Mediterranean fever in a 26-year old Lebanese man].
Falleboe M; Møller A
Ugeskr Laeger; 2000 Nov; 162(46):6263-4. PubMed ID: 11107992
[TBL] [Abstract][Full Text] [Related]
15. Colchicine treatment in children with familial Mediterranean fever.
Ozkaya N; Yalçinkaya F
Clin Rheumatol; 2003 Oct; 22(4-5):314-7. PubMed ID: 14579163
[TBL] [Abstract][Full Text] [Related]
16. Interferon alfa in protracted arthritis of familial Mediterranean fever: a robust alternative for synovectomy.
Ureten K; Calgüneri M; Onat AM; Ozçakar L; Ertenli I; Kiraz S
Ann Rheum Dis; 2004 Nov; 63(11):1527. PubMed ID: 15479914
[No Abstract] [Full Text] [Related]
17. [Recurrent pleurisy as sole manifestation of familial Mediterranean fever].
ten Oever J; de Munck DR
Ned Tijdschr Geneeskd; 2008 Apr; 152(15):887-90. PubMed ID: 18512530
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-alpha as treatment option in severe persistent uncontrolled bronchial asthma: an open label study].
Kroegel C; Bergmann N; Heider C; Moeser A; Happe J; Schlenker Y; Bartuschka B; Henzgen M; Walther R; Reissig A; Foerster M
Pneumologie; 2009 Jun; 63(6):307-13. PubMed ID: 19517357
[TBL] [Abstract][Full Text] [Related]
19. Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran.
Salehzadeh F; Emami D; Zolfegari AA; Yazdanbod A; Habibzadeh S; Bashardost B; Barak M; Feizi I; Azimi H; Jastan M; Khalafi J
Turk J Pediatr; 2008; 50(1):40-4. PubMed ID: 18365590
[TBL] [Abstract][Full Text] [Related]
20. Familial Mediterranean fever associated with menstruation. Efficacy of intermittent colchicine therapy.
Milano AM
Am J Gastroenterol; 1981 Oct; 76(4):363-4. PubMed ID: 7198867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
